In T2DM patients, elevated methylation levels of ADCY5 are associated with an increased risk of developing colon cancer, and in glioblastoma, ADCY5 functions as a tumor suppressor, implies that similar mechanisms could be at play in colorectal cancer. This evidence concerns the gene ADCY5 and colorectal cancer.